Current perspectives on the obesity hypoventilation syndrome

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 6, 2007, Pages 490-496

  Piper, Amanda J ^a,b   Grunstein, Ronald R ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hypercapnia; Obesity hypoventilation; Respiratory failure; Sleep

Indexed keywords

NEUROHORMONE;

ASSISTED VENTILATION; DISEASE COURSE; HUMAN; HYPERCAPNIA; LONG TERM CARE; LUNG MECHANICS; MORBIDITY; MORTALITY; NEUROMODULATION; OBESITY HYPOVENTILATION SYNDROME; RESPIRATION CONTROL; RESPIRATORY FAILURE; REVIEW; SLEEP DISORDERED BREATHING; UPPER RESPIRATORY TRACT OBSTRUCTION; WEIGHT REDUCTION;

ANIMALS; CARBON DIOXIDE; CIRCADIAN RHYTHM; HUMANS; OBESITY HYPOVENTILATION SYNDROME; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; RISK FACTORS;

EID: 34848874210     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282ef6894     Document Type: Review

References (59)

1. Flegal KM, Carroll MD, Ogden GL, Johnson CL. Prevalence and trends in obesity among US adults 1999-2000. JAMA 2002; 288:1723-1727.
2. Wu Y, Zhou B, Tao S, et al. Prevalence of overweight and obesity in Chinese middle-aged populations: current status and trend of development. Chin J Epidemiol 2002; 23:11-15.
3. 2) are increasing at a much faster rate than the obese group. Such trends have important implications for future health care problems and costs.
4. Nowbar S, Burkart KM, Gonzales R, et al. Obesity-associated hypoventilation in hospitalised patients: prevalence, effects and outcome. Am J Med 2004; 116:1-7.
5. Bickelman AG, Burwell CS, Robin ED, et al. Extreme obesity with alveolar hypoventilation: a Pickwickian syndrome. Am J Med 1956; 21:811-818.
6. Berg G, Delaive K, Manfreda J, et al. The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001; 120:377-383.
7. Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome. Hypoxemia during continuous positive airway pressure. Chest 2007; 131:1678-1684.
8. Piper AJ, Wang D, Yee BJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the initial management of patients with obesity hypoventilation syndrome [abstract]. Sleep Biol Rhythms 2006; 4 (Suppl 1):A11.
9. Yap JCH, Watson RA, Gilbey S, Pride NB. Effects of posture on respiratory mechanics in obesity. J Appl Physiol 1995; 79:1199-1205.
10. Jones RL, Nzekwu M-MU. The effects of body mass index on lung volumes. Chest 2006; 130:827-833.
11. Heinemann F, Budweiser S, Dobroschke J, Pfeifer M. Noninvasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007; 101:1229-1235.
12. Kessler R, Chaouat A, Schinkewitch P, Weitzenblum E. The obesity hypoventilation syndrome revisited. A prospective study of 34 consecutive cases. Chest 2001; 120:369-376.
13. Lazarus R, Sparrow D, Weiss ST. Effect of obesity and fat distribution on ventilatory function. Chest 1997; 111:891-898.
14. Collins LC, Hoberty PD, Walker JF, et al. The effect of body fat distribution on pulmonary function tests. Chest 1995; 107:1298-1302.
15. Leech JA, Onal E, Baer P, Lopata M. Determinants of hypercapnia in occlusive sleep apnea syndrome. Chest 1987; 92:807-813.
16. Laaban J-P, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005; 127:710-715.
17. Akashiba T, Akahoshi T, Kawahara S, et al. Clinical characteristics of obesity-hypoventilation syndrome in Japan: A multicenter study. Intern Med 2006; 45:1121-1125.
18. Pankow W, Podszus T, Gutheil T, et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol 1998; 85:1236-1243.
19. Ferretti A, Giampiccolo P, Cavalli A, et al. Expiratory flow limitation and orthopnea in massively obese subjects. Chest 2001; 119:1401-1408.
20. Kress JP, Pohlman AS, Alverdy J, Hall JB. Morbid obesity on oxygen cost of breathing at rest. Am J Respir Crit Care Med 1999; 160:883-886.
21. Lin C-C, Wu K-M, Chou C-S, Liaw S-F. Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol Neurobiol 2004; 139:215-224.
22. Pankow W, Hijjeh N, Schuttler F, et al. Influence of noninvasive positive pressure ventilation on inspiratory muscle activity in obese subjects. Eur Respir J 1997; 10:2847-2852.
23. Weiner P, Waisman J, Weiner M, et al. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax 1998; 53:39-42.
24. Lopata M, Onal E. Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 1982; 126:640-645.
25. Sugerman HJ, Fairman RP, Sood RK, et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992; 55 (2 (Suppl)):597S-601S.
26. Leech JA, Onal E, Aronson R, et al. Voluntary hyperventilation in obesity hypoventilation. Chest 1991; 100:1334-1338.
27. Garay SM, Rapoport D, Sorkin B, et al. Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1981; 124:451-457.
28. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med 1983; 75:81-90.
29. Berger KI, Ayappa I, Chatr-Amontri B, et al. Obesity hypoventilation sydrome as a spectrum of respiratory disturbances during sleep. Chest 2001; 120:1231-1238.
30. Chouri-Pontarollo N, Borel J-C, Tamisier R, et al. Impaired objective daytime vigilance in obesity-hypoventilation syndrome. Chest 2007; 131:148-155. This study found an association between daytime ventilatory responses to carbon dioxide and the amount of hypoventilation in REM. In addition, lower responders to carbon dioxide had higher objective daytime sleepiness. Impairments in daytime carbon dioxide response were reversible with effective nocturnal ventilation.
31. Jokic R, Zintel T, Gallagher CG, Fitzpatrick MF. Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax 2000; 55:940-945.
32. Burki NK, Baker RW. Ventilatory regulation in eucapnic morbid obesity. Am Rev Respir Dis 1984; 129:538-543.
33. El-Gamal H, Khayat A, Shikora S, Unterborn JN. Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest 2005; 128:3870-3874.
34. de Lucas-Ramos P, de Miguel-Diez J, Santacruz-Siminiani A, et al. Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med 2004; 98:961-967.
35. de Miguel Diez J, de Lucas Ramos P, Perez Parra JJ, et al. Analysis of withdrawal from noninvasive mechanical ventilation in patients with obesity-hypoventilation syndrome. Medium term results [in Spanish]. Arch Bronconeumol 2003; 39:292-297.
36. de Llano LP, Golpe R, Piquer MO, Carro CA. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity hypoventilation syndrome. Chest 2005; 128:587-594.
37. Rapoport DM, Garay SM, Epstein H, Goldring RM. Hypercapnia in the obstructive sleep apnea syndrome. A reevaluation of the 'Pickwickian syndrome'. Chest 1986; 89:627-635.
38. 2 homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol 2000; 88:257-264.
39. 2 load during respiratory events in obstructive sleep apnea. J Appl Physiol 2002; 93:917-924.
40. Ayappa I, Berger KI, Norman RC, et al. Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166:1112-1115.
41. Norman RG, Goldring RM, Clain JM, et al. Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol 2006; 100:1733-1741. Using a computer model, these authors identified the important impact that elevated bicarbonate concentrations have on the blunting of ventilatory responses to carbon dioxide, thereby linking acute sleep hypercapnia in response to apnoea with chronic diurnal hypoventilation.
42. Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007; 11:117-124. This clinical study found serum bicarbonate to be a highly sensitive predictor of hypercapnia in obese patients with OSA syndrome.
43. Hlavac MC, Catcheside PG, McDonald R, et al. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep 2006; 29:624-631. These authors found that sustained hypoxia delays arousal to inspiratory loading during sleep and increases the arousal threshold, identifying another potential pathway for the development and progression of sleep and eventually daytime respiratory failure.
44. Friedman JM. The function of leptin in nutrition, weight and physiology. Nutr Rev 2002; 60:S1-S14.
45. Correia ML, Rahmouni K. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 2006; 8:603-610. This is a good background review of how leptin and selective leptin resistance may contribute to several aspects of the metabolic syndrome.
46. O'Donnell CP, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999; 159:1477-1484.
47. Polotsky V, Wilson J, Smaldone M, et al. Female gender exacerbates respiratory depression in leptin-deficient obesity. Am J Respir Crit Care Med 2001; 164:1470-1475.
48. Tankersley CG, O'Donnell C, Daood MJ, et al. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol 1998; 85:2261-2269.
49. O'Donnell CP, Tankersley CG, Polotsky V. Leptin, obesity, and respiratory function. Respir Physiol 2000; 119:163-170.
50. Caro JH, Sinha MK, Kolaczynski JW, et al. Leptin: the tale of an obesity gene. Diabetes 1996; 45:1455-1462.
51. Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax 2002; 57:75-76.
52. Tatsumi K, Kasahara Y, Kurosu K, et al. T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127:716-721.
53. Shimura R, Tatsumi K, Nakamura A, et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 2005; 127:543-549.
54. Sanner BM, Kollhosser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004; 23:601-604.
55. Yee BJ, Cheung J, Phipps P, et al. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006; 73:209-212. This study identified a fall in circulating leptin levels in patients with OHS treated effectively with positive pressure therapy. In contrast, leptin levels in patients who were not compliant with treatment were unchanged, as were daytime blood gases.
56. Campo A, Fruhbeck G, Zulueta JJ, et al. Hyperleptinemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 2007; 30:232-239. This study reports an association between hyperleptinaemia and the reduction in respiratory drive and hypercapnic response in obese humans.
57. Redolfi S, Corda L, La Piana G, et al. Long-term noninvasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. Respir Med 2007; 101:1191-1195. This pilot study found lower leptin levels in OHS patients without OSA syndrome than in eucapnic obese patients without OSA syndrome. This is in contrast to the findings of previous studies conducted in obese patients with sleep disordered breathing, in whom leptin levels were found to be increased. In this subgroup of OHS patients, leptin increased following normalization of diurnal blood gases with nocturnal ventilation.
58. Lee S-D, Nakano H, Farkas GA. Adenosinergic modulation of ventilation in obese Zucker rats. Obes Res 2005; 13:545-555.
59. B receptors differentially modulate volume and frequency in ventilatory compensation in obese Zucker rats. J Appl Physiol 2007; 102:350-357. Evidence from this study conducted in obese Zucker rats raises the possibility that the GABAergic system may play a role in the impairment of ventilatory control in obesity.